Transdermal Estradiol in Menopausal Women Depresses Interleukin-6 without Affecting Other Markers of Immune Response

Publisher： Karger

E-ISSN： 1423-002x|53|2|114-117

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.53, Iss.2, 2002-04, pp. : 114-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Multicenter, Open-Label Study to Evaluate Satisfaction and Menopausal Quality of Life in Women Using Transdermal Estradiol/Norethindrone Acetate Therapy for the Management of Menopausal Signs and Symptoms

By  

Gynecologic and Obstetric Investigation, Vol. 59, Iss. 4, 2005-05 ,pp. : 212-219

Karger

Access to resources Recommend Favorite

Serum Soluble CD163 and Interleukin-6 Levels in Women with Ovarian Endometriomas

By  

Gynecologic and Obstetric Investigation, Vol. 66, Iss. 1, 2008-03 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Endometrial Development Was Improved by Transdermal Estradiol in Patients Treated with Clomiphene Citrate

By  

Gynecologic and Obstetric Investigation, Vol. 47, Iss. 4, 1999-05 ,pp. : 251-254

Karger

Access to resources Recommend Favorite

Half-Life of Estradiol in Postmenopausal Women

By  

Gynecologic and Obstetric Investigation, Vol. 45, Iss. 1, 1998-01 ,pp. : 45-48

Karger

Access to resources Recommend Favorite

Differential Levels of Interleukin 6 in Maternal and Cord Sera and Placenta in Women with Pre-Eclampsia

By  

Gynecologic and Obstetric Investigation, Vol. 52, Iss. 1, 2001-09 ,pp. : 60-65

Karger

Access to resources Recommend Favorite